FelsensteinJ, HorinoH, LamontSet al.PopG v3.3. A one-locus, two-allele genetic simulation program. University of Washington. Simulation assumptions: 100 populations of 10,000 ancestral vertebrates experiencing frequent inter-population migration (0.5); latent infection as a dominant allele with a prior frequency of 1e-5 conferring a selective advantage of one percent relative to non-latently-infected hosts, 2008.
HaqueA, RachinelN, QuddusMR, HaqueS, KasperLH, UsherwoodE. Co-infection of malaria and gamma-herpesvirus: exacerbated lung inflammation or cross-protection depends on the stage of viral infection. Clin Exp Immunol, 2004; 138:396–404.
6.
HislopAD, KuoM, Drake-LeeABet al.Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balance. J Clin Invest, 2005; 115:2546–2555.
7.
MossWJ, OtaMO, GriffinDE. Measles: immune suppression and immune responses. Int J Biochem Cell Biol, 2004; 36:1380–1385.
8.
NguyenYN, McGuffieBA, AndersonVE, WeinbergJB. Gammaherpesvirus modulation of mouse adenovirus type 1 pathogenesis. Virology, 2008; 380:182–190.
9.
ReddehaseMJ, BalthesenM, RappM, JonjicS, PavicI, KoszinowskiUH. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med, 1994; 179:185–193.
SchaubB, LauenerR, von MutiusE. The many faces of the hygiene hypothesis. J Allergy Clin Immunol, 2006; 117:969–977quiz 978.
12.
SteffensH.-P., KurzS, HoltappelsR, ReddehaseMJ. Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence. J Virol, 1998; 72:1797–1804.
13.
TibbettsSA, LohJ, Van BerkelVet al.Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection. J Virol, 2003; 77:7696–7701.
14.
WillerDO, SpeckSH. Long-term latent murine gamma-herpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo. J Virol, 2003; 77:8310–8321.
15.
YagerEJ, SzabaFM, KummerLW, LanzerKG, BurkumCE, SmileyST, BlackmanMA. γ-Herpesvirus-induced protection against bacterial infection is transient. Viral Immunol, 2009(in press).